Neuroradiology

, 50:653 | Cite as

Systematic review of reviews of risk factors for intracranial aneurysms

Invited Review

Abstract

Systematic reviews of systematic reviews identify good quality reviews of earlier studies of medical conditions. This article describes a systematic review of systematic reviews performed to investigate factors that might influence the risk of rupture of an intracranial aneurysm. It exemplifies the technique of this type of research and reports the finding of a specific study. The annual incidence of subarachnoid haemorrhage resulting from the rupture of intracranial aneurysms is estimated to be nine per 100,000. A large proportion of people who have this bleed, will die or remain dependent on the care of others for some time. Reliable knowledge about the risks of subarachnoid haemorrhage in different populations will help in planning, screening and prevention strategies and in predicting the prognosis of individual patients. If the necessary data were available in the identified reviews, an estimate for the numerical relationship between a particular characteristic and the risk of subarachnoid haemorrhage was included in this report. The identification of eligible systematic reviews relied mainly on the two major bibliographic databases of the biomedical literature: PubMed and EMBASE. These were searched in 2006, using specially designed search strategies. Approximately 2,000 records were retrieved and each of these was checked carefully against the eligibility criteria for this systematic review. These criteria required that the report be a systematic review of studies assessing the risk of subarachnoid haemorrhage in patients known to have an unruptured intracranial aneurysm or of studies that had investigated the characteristics of people who experienced a subarachnoid haemorrhage without previously being known to have an unruptured aneurysm. Reports which included more than one systematic review were eligible and each of these reviews was potentially eligible. The quality of each systematic review was assessed. In this review, 16 separate reports were identified, including a total of 46 eligible systematic reviews. These brought together research studies for 24 different risk factors. This has shown that the following factors appear to be associated with a higher risk of subarachnoid haemorrhage: being a woman, older age, posterior circulation aneurysms, larger aneurysms, previous symptoms, “non-white” ethnicity, hypertension, low body mass index, smoking and alcohol consumption of more than 150 g per week. The following factors appear to be associated with a lower risk of subarachnoid haemorrhage: high cholesterol, diabetes and use of hormone replacement therapy.

Keywords

Intracranial aneurysms Subarachnoid haemorrhage Systematic reviews Reviews Risk factors 

Notes

Acknowledgements

This systematic review of reviews was prepared as part of the @neurIST project, a European Union funded project (contract number FP6-IST-027703). I am grateful to the several people within @neurIST (www.aneurist.org) who commented on the documents as it was being prepared for that use. I am also grateful to Anne Eisinga at the UK Cochrane Centre who designed and ran the searches of PubMed and EMBASE.

Conflict of interest statement

I declare that I have no conflict of interest.

References

  1. 1.
    de Rooij NK, Linn FHH, van der Plas JA, Algra A, Rinkel GJE (2007) Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J NeurolNeurosurg Psychiat 78:1365–1372CrossRefGoogle Scholar
  2. 2.
    Allen C, Clarke M, Tharyan P (2007) International activity in Cochrane Review Groups with particular reference to India. Natl Med J India 20:250–255PubMedGoogle Scholar
  3. 3.
    Moher D, Tetzlaff J, Tricco AC, Sampson M, Altman DG (2007) Epidemiology and reporting characteristics of systematic reviews. PLoS Medicine 4:e78PubMedCrossRefGoogle Scholar
  4. 4.
    Dorhout Mees SM, van den Bergh WM, Algra A, Rinkel GJE (2007) Antiplatelet therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database of Systematic Reviews Issue 4. Art. no.: CD006184. DOI 10.1002/14651858.CD006184.pub2
  5. 5.
    Dorhout Mees SM, Rinkel GJE, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, van Gijn J (2007) Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database of Systematic Reviews Issue 3. Art. no.: CD000277. DOI 10.1002/14651858.CD000277.pub3
  6. 6.
    Whitfield PC, Kirkpatrick PJ (2001) Timing of surgery for aneurysmal subarachnoid haemorrhage. Cochrane Database of Systematic Reviews, Issue 2. Art. no.: CD001697. DOI 10.1002/14651858.CD001697
  7. 7.
    Mulrow CD (1987) The medical review article: state of the science. Ann Intern Med 106:485–488PubMedGoogle Scholar
  8. 8.
    Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M (2006) Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy. Health Technol Assess 10(34):1–204PubMedGoogle Scholar
  9. 9.
    Smith V, Devane D, Begley CM, Clarke M, Higgins S (2007) A systematic review and quality assessment of systematic reviews of fetal fibronectin and transvaginal cervical length for predicting preterm birth. Eur J Obstet Gynecol Reprod Biol 133(2):134–142PubMedCrossRefGoogle Scholar
  10. 10.
    Pilkington K, Boshnakova A, Clarke M, Richardson J (2005) “No language restrictions” in database searches: what does this really mean. J Altern Complement Med 11:205–207PubMedCrossRefGoogle Scholar
  11. 11.
    Edwards P, Clarke M, DiGuiseppi C, Pratap S, Roberts I, Wentz R (2002) Identification of randomized controlled trials in systematic reviews: accuracy and reliability of screening records. Stat Med 21:1635–1640PubMedCrossRefGoogle Scholar
  12. 12.
    Linn FHHH, Rinkel GJE, Algra A, van Gijn J (1996) Incidence of subarachnoid hemorrhage. Stroke 27:625–629PubMedGoogle Scholar
  13. 13.
    Rinkel GJE, Djibuti M, Algra A, Van Gijn J (1998) Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke 29:251–256PubMedGoogle Scholar
  14. 14.
    Morita A, Fujiwara S, Hashi K, Ohtsu H, Kirino T (2005) Risk of rupture associated with intact cerebral aneurysms in the Japanese population: a systematic review of the literature from Japan. J Neurosurg 102:601–606PubMedCrossRefGoogle Scholar
  15. 15.
    Feigin VL, Rinkel GJE, Lawes CMM, Algra A, Bennett DA, van Gijn J, Anderson CS (2005) Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke 36:2773–2780PubMedCrossRefGoogle Scholar
  16. 16.
    Ruland S, Gorelick PB (2005) Stroke in black Americans. Curr Cardiol Rep 7:29–33PubMedCrossRefGoogle Scholar
  17. 17.
    Feigin V, Parag V, Lawes CMM, Rodgers A, Suh I, Woodward M, Jamrozik K, Ueshima H (2005) Smoking and elevated blood pressure are the most important risk factors for subarachnoid hemorrhage in the Asia-Pacific region: an overview of 26 cohorts involving 306 620 participants. Stroke 36:1360–1365PubMedCrossRefGoogle Scholar
  18. 18.
    Teunissen LL, Rinkel GJE, Algra A, Van Gijn J (1996) Risk factors for subarachnoid hemorrhage: a systematic review. Stroke 27:544–549PubMedGoogle Scholar
  19. 19.
    Gieteling EW, Rinkel GJE (2003) Characteristics of intracranial aneurysms and subarachnoid haemorrhage in patients with polycystic kidney disease. J Neurol 250:418–423PubMedCrossRefGoogle Scholar
  20. 20.
    Gorelick PB, Weisman SM (2005) Risk of hemorrhagic stroke with aspirin use: an update. Stroke 36:1801–1807PubMedCrossRefGoogle Scholar
  21. 21.
    Auff E, Zeiler K, Holzner F, Wimmer S, Deecke L (1986) The significance of oral contraceptive use as a risk factor in cerebrovascular disease. Wiener Klinische Wochenschrift 98:304–310PubMedGoogle Scholar
  22. 22.
    Johnston SC, Colford JM, Gress DR (1998) Oral contraceptives and the risk of subarachnoid hemorrhage: a meta-analysis. Neurology 51:411–418PubMedGoogle Scholar
  23. 23.
    Qiu N-M, Meng Z-Q (2005) Relationship between physical exercise and sudden death and the physiological mechanism. Zhongguo Linchuang Kangfu 9:160–161Google Scholar
  24. 24.
    Bulsara KR, Raja A, Owen J (2005) HIV and cerebral aneurysms. Neurosurg Rev 28:92–95PubMedCrossRefGoogle Scholar
  25. 25.
    Sudlow C, Martinez Gonzalez NA, Kim J, Clark C (2006) Does apolipoprotein E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage? Systematic review and meta-analyses of 31 studies among 5961 cases and 17,965 controls. Stroke 37:364–370PubMedCrossRefGoogle Scholar
  26. 26.
    Vermeer SE, Rinkel GJE, Algra A (1997) Circadian fluctuations in onset of subarachnoid hemorrhage: new data on aneurysmal and perimesencephalic hemorrhage and a systematic review. Stroke 28:805–808PubMedGoogle Scholar
  27. 27.
    Feigin VL, Anderson CS, Rodgers A, Bennett DA (2002) Subarachnoid haemorrhage occurrence exhibits a temporal pattern—evidence from meta-analysis. Eur J Neurol 9:511–516PubMedCrossRefGoogle Scholar
  28. 28.
    Woo D, Broderick JP (2002) Spontaneous intracerebral hemorrhage: epidemiology and clinical presentation. Neurosurg Clin N Am 13:265–279PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  1. 1.UK Cochrane CentreNational Institute for Health ResearchOxfordUK

Personalised recommendations